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Cortical circuits control higher-order cognitive processes and their function is highly
dependent on their structure that emerges during development. The construction of
cortical circuits involves the coordinated interplay between different types of cellular
processes such as proliferation, migration, and differentiation of neural and glial cell
subtypes. Among the multiple factors that regulate the assembly of cortical circuits,
5-HT is an important developmental signal that impacts on a broad diversity of
cellular processes. 5-HT is detected at the onset of embryonic telencephalic formation
and a variety of serotonergic receptors are dynamically expressed in the embryonic
developing cortex in a region and cell-type specific manner. Among these receptors,
the ionotropic 5-HT3A receptor and the metabotropic 5-HT6 receptor have recently been
identified as novel serotonergic targets regulating different aspects of cortical construction
including neuronal migration and dendritic differentiation. In this review, we focus on the
developmental impact of serotonergic systems on the construction of cortical circuits and
discuss their potential role in programming risk for human psychiatric disorders.
Keywords: 5-HT, somatosensory cortex, cerebral cortex, development, plasticity, 5-HT3 receptor, 5-HT6 receptor,
circuit assembly
INTRODUCTION
The mammalian cerebral cortex is critical for sensory-motor
integration, higher-order cognitive functions, and emotional
regulation. It processes information through the activation of
neural networks composed of excitatory glutamatergic pyra-
midal neurons and local modulatory interneurons that release
γ-aminobutyric acid (GABA), neuropeptides, and vasoactive sub-
stances (Peters and Jones, 1984; Peters and Kara, 1985a,b; Baraban
and Tallent, 2004; Karagiannis et al., 2009; Tricoire and Vitalis,
2012). Developmental perturbations impacting the maturation
of cortical circuits can confer risk for neuropsychiatric disor-
ders (Insel, 2010; Thompson and Levitt, 2010; Marin, 2012).
Our labs have contributed to a model, in which such develop-
mental vulnerability is often restricted to sensitive periods. The
concept of sensitive developmental periods for the indelible mod-
ulation of complex behaviors is similar to that described for
sensory systems (i.e., visual cortex, ocular dominance plasticity),
but modulating factors, and underlying mechanisms are much
less well-understood.
Building cortical circuits relies on a series of precisely timed
events that take place mainly during embryonic and early post-
natal development (reviewed in Marin and Rubenstein, 2001;
Bystron et al., 2008; Corbin et al., 2008; Batista-Brito and Fishell,
2009; Rakic, 2009; Vitalis and Rossier, 2011). Critical components
include the proliferation, migration, and differentiation of neu-
rons and glial cells, with differentiation including the appropriate
growth and guidance of axons toward their targets. These steps are
genetically programmed and phylogenetically conserved, yet they
are malleable and plastic. As cell-autonomous signaling unfolds
over time, the various cortical cell-types are continuously in
contact with and responding to their environment. Cell extrin-
sic signals are very diverse in nature and include monoamines,
guidance cues, growth factors, cell adhesion molecules, and var-
ious components of the extracellular matrix. In particular, the
monoamine 5-HT has emerged as an important regulator of neu-
ral circuit formation (previously reviewed in Gaspar et al., 2003;
Vitalis and Parnavelas, 2003).
In developing rodent embryos, cortical 5-HT mainly arises
from placental sources at the onset of cortical development and
from serotonergic afferents by E16–E17 (Bonnin et al., 2011).
This dual source of 5-HT is conserved in humans and permits
5-HT signaling during development, even before embryonic sero-
tonergic neurons have differentiated and are able to release 5-HT.
Not surprisingly, 5-HT modulates neuronal proliferation, migra-
tion, and differentiation, and is implicated in the etiology of
many neuropsychiatric disorders, including mental retardation,
autism, depression, and anxiety (for reviews, see Berger-Sweeney
and Hohmann, 1997; Levitt et al., 1997; Whitaker-Azmitia, 2001;
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Gu, 2002; Gaspar et al., 2003; Homberg et al., 2009; Oberlander
et al., 2009; Daubert and Condron, 2010; Lesch and Waider,
2012). In the context of developmental plasticity under normal
conditions as well as in disease, it is important to appreciate
that 5-HT signaling is influenced by many factors, including
nutrition (Serfaty et al., 2008), perinatal stress (Peters, 1990;
Papaioannou et al., 2002a,b), infection (Winter et al., 2008, 2009),
5-HT metabolism and storage (Cases et al., 1996; Vitalis et al.,
1998, 2007; Noorlander et al., 2008; Popa et al., 2008), genetic
alterations (Lira et al., 2003;Murphy and Lesch, 2008; Pluess et al.,
2010; Karg et al., 2011; Bonnin et al., 2011), and pharmacological
compounds such as selective 5-HT reuptake inhibitors (Ansorge
et al., 2004, 2008).
Here we review findings demonstrating that early-life 5-HT
signaling regulates cellular events implicated in the assembly of
cortical circuits. We highlight recent studies that have revealed
the role of specific 5-HT receptors in the construction of such
circuits: the ionotropic 5-HT type 3A receptor (5-HT3A) and
the metabotropic 5-HT type 6 receptor (5-HT6). Finally, we
review clinical studies suggesting that altered 5-HT homeostasis
or signaling could increase risk for human stress-related psy-
chopathologies such as mood and anxiety disorders.
STRUCTURE AND DEVELOPMENT OF THE RODENT
CEREBRAL CORTEX
NEURONAL COMPONENTS
The cerebral cortex of adult mammals is a laminated structure
comprised of six layers that each contain a complement of pyra-
midal (glutamatergic) and non-pyramidal (GABAergic) neurons
(Peters and Jones, 1984). Pyramidal neurons make up ∼80%
of all adult cortical neurons, sending excitatory output axons
to other cortical areas and to distant parts of the brain (Peters
and Kara, 1985a; Thomson and Lamy, 2007; Spruston, 2008).
The vast majority of cortical GABAergic cells are interneurons
that only make local connections. GABAergic interneurons are
extremely diverse, differing in shape, electrophysiological proper-
ties, and the combination of neuropeptides and calcium-binding
proteins that they express (Peters and Kara, 1985b; Cavanagh
and Parnavelas, 1988; DeFelipe, 1993; Kawaguchi and Kondo,
2002; Blatow et al., 2005; Tomson and Lamy, 2007; PING et al.,
2008; Karagiannis et al., 2009; Xu et al., 2010; Vitalis and Rossier,
2011; Tricoire and Vitalis, 2012; DeFelipe et al., 2013). Using
these differentiating characteristics, one can at a first approxima-
tion distinguish four main classes of interneurons populating the
somatosensory cortex (PING et al., 2008; DeFelipe et al., 2013).
First, fast-spiking interneurons that express parvalbumin (Parv),
and act as an inhibitory gate for incoming sensory information
(Inoue and Imoto, 2006; Sun et al., 2006). Second, adapting mar-
tinotti cells that express somatostatin (SOM), and are thought
to control dendritic information through local feedback inhibi-
tion (Karube et al., 2004). Third, adapting bipolar interneurons
that express vasoactive intestinal peptide (VIP) and calretinin
(CR), and preferentially target other interneurons and receive
direct input from the thalamus (Férézou et al., 2007; Vitalis and
Rossier, 2011). Fourth, adapting neurogliaform interneurons that
express neuropeptide Y (NPY) and/or nitric oxide (NO), and that
are responsible for the slow GABAergic inhibition of pyramidal
cells and interneurons (Karagiannis et al., 2009; Oláh et al., 2009;
Perrenoud et al., 2012a,b; Tricoire and Vitalis, 2012).
DEVELOPMENT OF THE CEREBRAL CORTEX
Origins and migration of pyramidal neurons and the formation of
cortical layers
The cerebral cortex develops from neuroepithelial germinal cells
of the telencephalic pallium and subpallium that massively pro-
liferate (from E11 to E12 in mice), to form the cerebral vesicles.
The first neurons generated, Cajal-Retzius (C-R) cells and sub-
plate (SP) cells, form transient and heterogeneous populations
of cells that originate from both pallial and subpallial territories
and establish the preplate (PP; Boulder Committee, 1970; Uylings
et al., 1990; Bystron et al., 2008). SP and reelin secreting C-R cells
provide positioning cues and instructions to developing cortical
neurons and afferents (Supèr et al., 2000; Soriano and del Rio,
2005; Herz and Chen, 2006; Lakatosova and Ostatnikova, 2012).
The first pyramidal neurons generated arise sequentially from the
cortical ventricular zone (VZ), from which they translocate or
migrate radially to form a layer within the PP, the so-called cor-
tical plate (CP), thus splitting the PP into a superficial marginal
zone (MZ; presumptive layer I containing the C-R cells) and a
deep SP. At the beginning of CP formation (E13–E14 in mice),
pyramidal cells are generated from radial glial cells (RGCs),
whereas later (E15–E17 in mice), they mainly originate from
intermediate progenitor cells (IPC; or basal progenitors) deriv-
ing from RGC cells (see Kriegstein and Noctor, 2004; Noctor
et al., 2004; Corbin et al., 2008 for reviews). The neurons of the
CP assemble into layers II–VI in an “inside-out” sequence: the
deepest cellular layers are assembled first and those closest to the
surface last.
Origins and migration of GABAergic neurons
In rodents, most GABAergic neurons are generated outside the
cortical VZ, mainly in the medial (E11–E14 in mice) and the
caudal (E14–E17 in mice) parts of the ganglionic eminence
(MGE and CGE, respectively) in the basal telencephalon (for
reviews, seeMarin andRubenstein, 2001;Wonders andAnderson,
2006; Batista-Brito and Fishell, 2009; Rudy et al., 2011; Vitalis
and Rossier, 2011), and more ventrally in the entopeduncu-
lar region (AEP) and the preoptic region (POA; Gelman et al.,
2009). These areas are specified through a combination of distinct
transcription factors and morphogenes, and produce different
classes of interneurons. The ventral and dorsal parts of the MGE
express the homeobox transcription factor Lhx6 and generate two
large classes of interneurons: fast-spiking/Parv+ interneurons and
adapting/SOM+ interneurons (Xu et al., 2004; Butt et al., 2005,
2007; Miyoshi et al., 2007;Wonders et al., 2008). Later, the CGE—
a region that expresses the transcription factor Gsh2 (Fogarty
et al., 2007) but lacks the transcription factors Nkx2.1, Nkx6.2,
and Lhx6 (Flames et al., 2007)—generates an average of 30% of
the total population of GABAergic interneurons, which mainly
express VIP, CR, and NPY (Lee et al., 2010; Vucurovic et al.,
2010; Rudy et al., 2011; Vitalis and Rossier, 2011). Once produced,
interneurons migrate toward the CP. They initially follow paral-
lel migratory streams, first in the intermediate zone and MZ, and
later along the subventricular zone (SVZ), before they switch their
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migratory mode and incorporate into the developing CP through
radial migration. Interestingly, some of the later generated mainly
CGE-derived interneurons pause longer (until around P1–P2) in
the SVZ before entering CP. In mice, cortical migration is almost
completed by P4, and followed by cortical expansion. However,
during the first postnatal days and decreasing with age the SVZ
retains the capacity to produce CR-expressing interneurons that
incorporate into the cerebral cortex at postnatal stages (Inta et al.,
2008; Riccio et al., 2012). These key events are recapitulated in
Figure 2.
SOURCES OF 5-HT TO THE RODENT CORTEX
5-HT SYNTHESIS
5-HT is synthesized from the essential amino-acid tryptophan.
In the blood stream, 90% of tryptophan is linked to serum-
albumin. A proportion reaching ∼10% when the blood-brain
barrier becomes fully functional (postnatal day 12) and decreas-
ing with age is free to cross the developing blood-brain barrier
(Ribatti et al., 2006). Tryptophan is accumulated in 5-HT produc-
ing cells by a non-specific transporter with high affinity to several
uncharged aromatic amino-acids. Tryptophan is then hydroxy-
lated in these cells into 5-hydroxytryptophan by the tryptophan
hydroxylase. Tryptophan hydroxylase type 2 (Tph2) is expressed
in serotonergic neurons of the raphe nuclei (Côté et al., 2003;
Walther et al., 2003), while peripheral tissues mostly express tryp-
tophan hydroxylase type 1 (Tph1). 5-hydroxytryptophan is then
further decarboxylated into 5-HT by the aromatic amino-acid
decarboxylase (AADC). 5-HT is catabolized in the cytoplasm of
5-HT transporter (SERT) expressing cells by monoamine oxidase
A or B (MAOA or MAOB). MAOA has higher affinity to 5-HT
than MAOB, but both enzymes are co-expressed in rodent sero-
tonergic neurons between E12 and P7 (Vitalis et al., 2002a). After
P7, the expression of MAOB becomes predominant, and MAOA
deficiency could be partially compensated for by the increased
expression of MAOB in serotonergic neurons (Cases et al., 1996;
Vitalis et al., 2002a; Cheng et al., 2010).
5-HT of the embryonic telencephalon is not only produced
locally by serotonergic neurons of the raphe nuclei, but also orig-
inates from extra-CNS (embryonic periphery, placental) as well
as extra-embryonic (maternal) sources. In the two following sec-
tions, we briefly recapitulate the development of the serotonergic
system and review the various sources of telencephalic 5-HT
during embryonic and early postnatal life.
DEVELOPMENT OF THE SEROTONERGIC SYSTEM IN RELATION TO
TELENCEPHALIC DEVELOPMENT
Serotonergic neurons of the brainstem are subdivided into 9
groups forming two clusters: the caudal division (B1–B4; includ-
ing the raphe pallidus, obscurus, magnus, and pontis) projecting
to the spinal cord and the cerebellum, and the rostral division
[B5–B9; including the dorsal (B6, B7) and median raphe nuclei
(B5, B8)] projecting to the forebrain (Lidov and Molliver, 1982;
Steinbusch and Nieuwenhuys, 1983; Törk, 1990; Figure 1A).
Recent genetic and developmental approaches revealed differ-
ential rhombomeric identities of raphe 5-HT neurons, which
introduce a new layer of functional classification (Jensen et al.,
2008; Kiyasova and Gaspar, 2011). Together with genetic tracing
and topographic projection mapping, we will soon have a much
better understanding of the anatomical organization of the 5-HT
systems.
In mice, dorsal raphe neurons differentiate in the brainstem
by E10–E11 (E12–E15 in rats). This period coincides with the
beginning of telencephalic vesicle formation (Wallace and Lauder,
1983; Aitken and Törk, 1988). Serotonergic neurons generated
rostral to the isthmus (B6–B9 groups; dorsal and median raphe)
send axons only one day after their genesis. These axons reach
the cortico-striatal junction by E14 in mice (by E16 in rats;
Wallace and Lauder, 1983; Figure 1B), during the peak of migra-
tion of cortical GABAergic interneurons generated in the MGE.
5-HT-containing axons enter the cortical anlage as two tangen-
tial streams, one above and the other below the CP (Wallace and
Lauder, 1983; Aitken and Törk, 1988). The former is distributed
in the MZ where pioneering C-R cells are located and with which
they are in close appositions, making transient synaptic contacts
(Radnikow et al., 2002; Janusonis et al., 2004).
Below the CP, 5-HT afferents are mainly restricted to the
IZ and the SP (Wallace and Lauder, 1983). At E14, the devel-
oping cerebral cortex (Bayer and Altman, 1991) and the gan-
glionic eminences produce deeper-layer neurons (glutamater-
gic and GABAergic, respectively) that are in the process of
migration to their final positions. By E16–E17 in mice, tha-
lamocortical axons (TCAs) penetrate the cortical anlage and
are in close apposition with 5-HT axons running in the IZ.
In parallel, cortical neurons begin to establish their polarity,
sending their axons toward their respective targets and devel-
oping numerous dendritic processes. At the end of corticogene-
sis, 5-HT axons gradually arborize sending numerous branches
into the CP (Wallace and Lauder, 1983). During this period a
large proportion of GABAergic interneurons enter the CP where
they radially migrate to reach their final positions (see above).
Progressively, serotonergic axons become evenly distributed in
the different cortical territories and show their mature pat-
tern of innervation by P21 (Steinbusch, 1981). However, dor-
sal raphe and median raphe projections differ anatomically.
The dorsal raphe projections have been described as generally
thin, displaying numerous branches with pleiotropic varicosi-
ties and preferentially arborize in cortical layers IV and V that
receive thalamic inputs. By contrast, median raphe projections
are characterized by large spherical varicosities that can form
true chemical synapses (Törk, 1990). They preferentially arborize
in layer I and lower white matter, give collaterals that could
surround neuronal cell bodies and proximal dendrites, and pref-
erentially contact interneurons containing VIP- and cholecys-
tokinin (CCK) in various species (Törk, 1990; Hornung and
Celio, 1992; Férézou et al., 2007). Interestingly, in the mature
brain, a dense plexus of 5-HT-positive fibers is present in the
SVZ, in close apposition with progenitor cells of this region
(Jahanshahi et al., 2011). At all stages 5-HT could be released
along the entire axonal network thus diffusing into the entire
extracellular fluid. It is still not clear whether subsets of serotoner-
gic axons preferentially release 5-HT in synaptic clefts vs. volume
transmission.
OTHER SOURCES OF 5-HT
Although 5-HT is likely to act as a trophic or instructive fac-
tor during early periods of cortical development, its sources have
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FIGURE 1 | Development and location of serotonergic neurons and
projections. (A) Drawing of a sagittal section of an E11 mouse brain
illustrating the location of 5-HT neurons caudal to the isthmus (is). (B)
Drawing of a sagittal section of an E15 mouse brain showing the
5-HT-containing cell groups and their main projections. 5-HT cell groups are
classically distributed in nine groups (B1–B9). The posterior groups (B1–B3;
yellow dots) mainly consist in raphe magnus sending projections to the
medulla, the spinal cord, and the periphery (yellow dots and arrow). The
raphe dorsal (B6, B7) located dorsal to the medial longitudinal fasiculus (mlf)
and the raphe median (B5, B8) send ascending serotonergic innervations
destine to the telencephalon and diencephalon (purple). Serotonergic
afferents innervating the forebrain travel initially together along the median
forebrain bundle (mfb). Arrows indicate regions where axons are seen to
deviate from the major ascending pathway: along the fasciculus retroflexus
(fr) toward the habenula, in the hypothalamus (hyp), the striatum, and the
septum (se). (C) Drawing of a sagittal section of a mature mouse brain
showing the 5-HT-containing cell groups and their main projections. Arrows
indicate regions highly innervated by 5-HT afferents: the hypothalamus (hyp),
the amygdala (amg), the thalamus (th), the accumbens (acc), the striatum (st),
the olfactory bulb (ob), the cerebral cortex (cx), and the hippothalamus (hip).
In the cerebral cortex, layers V and VI receive preferentially afferents arising
from the dorsal raphe (light purple) while layer I receives afferents mainly
arising from the median raphe (dark purple). Drawings are adapted from
Wallace and Lauder (1983) and Steinbusch and Nieuwenhuys (1983).
remained elusive. Evidence indicates that 5-HT is supplied to the
developing cerebral cortex before 5-HT axons reach their tar-
gets or even before serotonergic neurons are generated. In line
with this observation, 5-HT receptors are expressed in the ros-
tral forebrain, craniofacial region, and peripheral region days
before serotonergic axons enter these regions (Buznikov et al.,
2001). Furthermore, ex vivo application of 5-HT or alteration
of 5-HT levels during early embryonic stages can alter normal
development of various embryonic structures before seroton-
ergic neurons have innervated these structures (Lauder, 1988;
Shuey et al., 1992; Moiseiwitsch and Lauder, 1995; Whitaker-
Azmitia et al., 1996; Buznikov et al., 2001; Witaker-Azmitia,
2001). Recently, the placenta (that is of embryonic origin) has
been identified as an important source of 5-HT for the develop-
ing embryo (Bonnin et al., 2011; Figure 2). Syncytiotrophoblastic
cells of the placenta contain Tph1, AADC, and MAO (Grimsby
et al., 1990; Shih et al., 1990), and convert tryptophan of mater-
nal origin into 5-HT as soon as E10–E11 (Bonnin et al., 2011).
Genetically modified mice in which 5-HT neurons fail to fully
differentiate or to produce normal amounts of 5-HT levels do
not display severe cortical defects when gestating in heterozygous
dams with an almost unaltered serotonergic system, suggesting
that sources of 5-HT independent of embryonic serotonergic neu-
rons could be sufficient to permit normal cortical development.
Examples include mice lacking the transcription factors Lmx1b
(Smidt et al., 2000) or Pet-1 (Hendricks et al., 1999), in which all
or 70–80% of 5-HT raphe neurons fail to develop, respectively,
and in mice lacking Tph2 Alenina et al., 2009; Gutknecht et al.,
2012; Migliarini et al., 2012. Further analysis revealed that Pet-1
knockout embryos developing in heterozygous dams have normal
5-HT levels before the closure of the brain-blood barrier (before
E15; Daneman et al., 2010). In addition, SERT+/− embryos devel-
oping in SERT−/− or wild type dams had similar levels of 5-HT
before E15 (Bonnin et al., 2011). Together, these results revealed
that the placenta is an important source of 5-HT for the embry-
onic CNS before E15 but questioned the contribution of maternal
5-HT that was suspected in earlier studies (Shuey et al., 1992;
Yavarone et al., 1993; Côté et al., 2003, 2007).
Outside the CNS, 5-HT is also synthesized in the periphery
of the developing embryo. In particular, high levels of 5-HT are
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FIGURE 2 | Cortical development in relation to sources of 5-HT.
Cortical neurogenesis in the mouse neocortex occurs from embryonic
day E10–11 (left) to E17 (right) begins with an intense proliferation of the
progenitor cells located in the ventricular zone (VZ) of the subpallium and
more ventrally of the pallium (not shown in the drawing). These
populations of cells give rise to most of the GABAergic neurons
(subpallium) and glutamatergic neurons and glial cells (pallium) of the
cerebral cortex. Once generated, neurons migrate toward the pial surface
and complete their differentiation in the cortical plate (CP). Glutamatergic
neurons destined to populate the deeper layers of the cortex are
generated and then migrate away form the VZ earlier than the neurons
destined for progressively more superficial layers. GABAergic neurons
arise from more ventral structure and migrate tangentially in the
developing CP. On E13, the cerebral wall is bilaminar consisting of the VZ
and overlying primitive plexiform layer. By E17–E20 the thickness of the
overlying intermediate zone/with matter and developing cortical plate are
at their maximum widths, with all neuronal cells having exited the cell
cycle and migrated to their final laminar distribution within the developing
cortex. At this stage GABAergic neurons enter the CP by radial
migration. The cortical anlage is vascularized very early and carries
platelets and mast cells that could provide 5-HT to the developing
embryo. During the initial phase of cortical development 5-HT is mainly
synthesized in the placenta while later on it is produced by serotonergic
neurons of the embryo (gray is high and blue is low). IZ, intermediate
zone; PPL, primordial plexiform layer; SP, subplate; SVZ, subventricular
zone [Adapted from Uylings et al. (1990) and Corbin et al. (2008)].
produced in the myenteric plexus (from E15 to E16), by ente-
rochromaffin cells of the lining lumen of the digestive tract (from
E18), by neuroepithelial cells of the respiratory tracts, by pinealo-
cytes (from E11 to E12) and by parafollicular cells of the thyroid.
After being released from 5-HT producing cells, 5-HT could be
taken up by SERT expressing cells including platelets and mast
cells (Jankovic, 1989; Zhuang et al., 1996) that become numer-
ous around E12 in mice. These cells could cross the blood-brain
barrier and transit across blood vessels that start to invade the
developing cortex by E10–E11 in mice (Daneman et al., 2010).
However, overall peripheral structures are thought to contribute
only to a small proportion of cortical 5-HT during development.
In addition, sensory thalamic neurons projecting to primary
sensory cortices (i.e., somatosensory, visual, auditory) transiently
express SERT (E15–P15) and the vesicular monoamine trans-
porter type 2 (VMAT2) that are respectively responsible for
the uptake and packaging of 5-HT into synaptic vesicles (Cases
et al., 1996, 1998; Vitalis et al., 1998; Lebrand et al., 1996, 1998;
Gaspar et al., 2003; Vitalis and Parnavelas, 2003; Figure 2). While
equipped with these transporters, thalamic neurons may release
5-HT in an activity-dependent fashion by transiently adopting a
serotonergic phenotype even without expressing TPH or MAOs
(Vitalis et al., 2002a). Interestingly, it has been suggested that
TCAs could be implicated in the proliferation and migration of
glutamatergic neurons, and it is thus possible that release of 5-HT
by TCAs could contribute to the regulation of these processes
(Kennedy and Dehay, 1997; Edgar and Price, 2001). Fate map-
ping of SERT-expressing cells in mice revealed that in addition to
the thalamus, also the cortex, hippocampus, hypothalamus, and
brainstem harbor neurons that transiently adopt a serotonergic
phenotype (Narboux-Nême et al., 2008). Within the cortex, tran-
sient SERT expression starts between E15 and P0 and is confined
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to layers V and VI (infralimbic, prelimbic, and anterior cingulate
cortex) or layers II, V, and VI (posterior cingulate and retrosple-
nial cortex). The role of 5-HT signaling by these neurons remains
to be elucidated. However, because of the spatial and temporal
aspects of this phenomenon, it is tempting to speculate that tran-
sient serotonergic neurons might influence cortical maturation
and circuit formation.
5-HT RECEPTORS WITH SPECIFIC ATTENTION TO THE
5-HT3A AND 5-HT6 SUBTYPES
TRANSDUCTION PATHWAYS
At least 14 genes that encode for 5-HT receptors have been identi-
fied and cloned in the mammalian brain (Hoyer et al., 1994, 2002;
Raymond et al., 2001; Hannon and Hoyer, 2008; Millan et al.,
2008). In addition, alternative splicing and RNA editing add to
the diversity of 5-HT receptors. With the exception of the 5-HT3
receptors, all 5-HT receptors are coupled to G-proteins, leading to
a categorization into four groups according to their second mes-
senger coupling pathways. The 5-HT1 and 5-HT5 receptors are
coupled to Gi/Go proteins and exert their inhibitory effects on
adenylate cyclase inhibiting cAMP formation. The 5-HT2 recep-
tors are coupled to Gq proteins and stimulate phospholipase C to
increase the hydrolysis of inositol phosphates and elevate intra-
cellular Ca2+. The 5-HT4,6,7 receptors are coupled to Gs proteins
and are positively linked to adenylate cyclase and increase cAMP
formation. 5-HT3 (5-HT3A and 5-HT3B) receptors belong to a
family of ligand-gated ion channel receptors that include nicotinic
acetylcholine receptors, GABAA receptors, and glycine receptors
and that are modulated by intracellular cyclic AMP (Hoyer et al.,
1994). The 5-HT3 receptors respond to neurotransmitter release
via direct (through the 5-HT3 receptor itself) or indirect (via the
activation of the voltage-gated Ca2+ channels) increase of Ca2+
entry into the cell (reviewed in Chameau and van Hooft, 2006).
5-HT3 receptors are composed of five subunits, with the major-
ity being homomers of 5-HT3A receptors. Heteromeric 5-HT3AB
receptors have been observed in specific brain regions and display
lower Ca2+ permeability than the homomeric 5-HT3A receptors
(Tecott et al., 1993; Morales and Bloom, 1997; Davies et al., 1999;
Morales and Wang, 2002). Furthermore, the co-assembly of the
5-HT3 with the alpha4 subunit of the nicotinic acetylcholine has
been reported to confer increased permeability to Ca2+ (Kriegler
et al., 1999; Chameau and van Hooft, 2006).
EXPRESSION PATTERNS
The expression of 5-HT receptors during cortical development is
not yet fully characterized. However, the recent use of transgenic
animals (i.e., carrying the GFP/YFP under the control of a spe-
cific 5-HTR promoter) and open in situ hybridization databases
(i.e., Allen Brain Atlas) have started to provide valuable insights.
For example, 5-HT1A,F are expressed in neocortical prolifera-
tive zones in E14.5 rodent brain (Hillion et al., 1994; Bonnin
et al., 2006) and the 5-HT2B are expressed in the proliferative
zones of the human occipital cortex (Lidov and Rakic, 1995).
The 5-HT1A,B,D, 5-HT2A, 5-HT2C, and 5-HT3A, are expressed
in specific subpopulations of postmitotic neurons (Hillion et al.,
1994; Johnson and Heinemann, 1995; Tecott et al., 1993; Morales
and Bloom, 1997; Bonnin et al., 2006; Chameau et al., 2009;
Vucurovic et al., 2010; Tanaka et al., 2012), whereas the 5-HT6 is
expressed in both migrating interneurons and pyramidal neurons
(Riccio et al., 2011; Figure 3). Although a complete developmen-
tal time-course of 5-HT6 expression in the dorsal pallium is not
available, 5-HT6 expression is detected in the developing rat brain
as early as E12 and is maintained stable until adult age (Grimaldi
et al., 1998). In adulthood, 5-HT6 receptors are expressed in
layers II–VI of the rodent postnatal and mature cerebral cortex
(Ward et al., 1995; Hamon et al., 1999; Gerard et al., 1997), and
pyramidal neurons and glial cells of the human prefrontal cor-
tex (Marazziti et al., 2013). Interestingly, human prefrontal cortex
expression of the 5-HT6 receptor peaks in toddlers (Lambe et al.,
2011).
The dynamic expression pattern of the 5-HT3A receptor is
recapitulated in Figure 4. In the mouse cortical anlage, 5-HT3A
is expressed as early as E12 in PP neurons expressing reelin
(C-R cells) and/or GABA (Chameau et al., 2009; Vucurovic et al.,
2010). During the period of intense production of GABAergic
neurons, the 5-HT3A is expressed by newly postmitotic (Tuj-
1+) neurons located in the CGE and AEP/PO, where about
30% of cortical GABAergic neurons are generated (Lee et al.,
2010; Vucurovic et al., 2010). Using homochronic in utero graft-
ing in combination with a transgenic mouse line expressing
GFP under the control of the 5-HT3A promoter (5-HT3A:GFP
animals) we have shown that this expression was protracted
FIGURE 3 | Expression of the 5-HT6 receptor. (A) Drawing shown in
Figure 2 has been modified in order to depict the expression of 5-HT6 at
E17–E18. At this stage 5-HT6 is expressed in developing interneurons
(green), in differentiating pyramidal neurons (pink). (B,C) Expression of
5-HT6 in cell cultures (E17 + 1DIV) in GABAergic neurons expressing GAD65
(green) and in pyramidal neurons labeled with TOM after in utero
electroporation performed at E14.5. Scale bar: 10μm.
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FIGURE 4 | Expression of the 5-HT3A receptor. (A–C) Drawings shown in
Figure 2 have been modified in order to depict the expression of 5-HT3A
(green) during development. Note that 5-HT3A is expressed by pioneer
Cajal-Retzius cells of the marginal zone (MZ; A, E12) and by a subpopulation
of late generated GABAergic neurons arising from the CGE (E14 and
E16–E17). (A′–C′) Corresponding photomicrographes of the drawings
presented in (A–C). Scale bar: (A) 20μm; (B) 100μm; (C) 120μm.
in two large subpopulations of cortical GABAergic neurons
that could be distinguished based on their electrophysiological
properties, molecular contents, and morphologies. The first one
corresponded to multipolar interneurons expressing NPY and
displaying late spiking and accommodating properties while the
second one corresponded to small bipolar and doublet bou-
quet interneurons expressing VIP and displaying adapting and
bursting properties (Vucurovic et al., 2010; Lee et al., 2010;
Rudy et al., 2011; Vitalis and Rossier, 2011). During postna-
tal stages and decreasing with age 5-HT3A receptors are also
expressed in young neurons (doublecortin+ and/or CR+), which
are generated in the SVZ and migrate toward the olfactory bulb
and various cortical and subcortical regions (Inta et al., 2008;
Riccio et al., 2012). In addition, we recently found that 5-HT3A
receptors are expressed during postnatal development (P0–21)
in a pool of migrating interneurons, which are probably gener-
ated from local transient amplifying precursors within the white
matter, ventral to the anterior cingulate cortex (Riccio et al.,
2012).
IMPACT OF 5-HT IMBALANCE ON CORTICAL CIRCUIT
ASSEMBLY
5-HT AND CELL PROLIFERATION
It has been postulated for some time that 5-HT regulates the
proliferation of a wide variety of cell types including cortical
neurons. Indeed, studies that pharmacologically or genetically
deplete maternal and embryonic brain 5-HT levels or restrict
tryptophan availability have found reduced embryonic brain size
as a major consequence. Chronic pCholophenylalanin (PCPA)-
treatment, which inhibits 5-HT synthesis, alters the proliferation
of serotonergic target cells (i.e., the hippocampal field and cere-
bral cortex) when administrated daily to pregnant dams from E8
to E12 (Lauder and Krebs, 1978) or from E12 to E17 (Vitalis
et al., 2007). Similar observations were made after reserpine-
treatments that deplete 5-HT (Holson et al., 1994), or after lesions
of serotonergic fibers such as those observed after high cocaine
administration (Clarke et al., 1996). However, there are several
drawbacks in these initial studies. For example, chronic treat-
ments are likely to induce secondary alterations, which might
be ultimately responsible for the effects observed. Another major
problem is the selectivity of the neurotransmitter system affected.
This is particularly problematic for reserpine-treatments that
deplete all monoamines. Recently, the generation of transgenic
models selectively targeting specific 5-HT-related genes in differ-
ent neuronal populations have started to provide more specific
insights. For instance mice deficient for tph1 or tph2 showed
body weight reduction and delayed maturation of upper corti-
cal layers (Côté et al., 2007; Alenina et al., 2009; Narboux-Neme
et al., 2013). A 2 h pulse labeling experiment revealed that het-
erozygous embryos growing in null mutant tph1−/− mice showed
an ∼30% reduction of BrdU-positive cells in the VZ when com-
pared to tph1−/− embryos growing in heterozygous mice (Côté
et al., 2007). Together these studies suggest that 5-HT regulates
the proliferation of neuronal precursors, but additional studies
are needed to refine these initial observations and confirm this
conclusion.
Initial in vitro studies have failed to show that 5-HT could
modulate the proliferation of cortical progenitors (Dooley et al.,
1997; Lavdas et al., 1997), as the proportion of cells that integrated
BrdU was similar in untreated and treated cultures. However,
since 5-HT had an anti-apoptotic effect the dilution of BrdU+
cells may have masked this proliferative effect. Furthermore, it
was demonstrated that stimulation of the 5-HT2 and 5-HT3 had
no effect on cortical neurogenesis (Dooley et al., 1997; Vitalis and
Parnavelas, 2003). This is consistent with the fact that 5-HT3A
is not expressed in pallial and subpallial proliferative zones
(Vucurovic et al., 2010). In contrast, the 5-HT1A appears to medi-
ate such a role. In vivo, PCPA-induced microcephaly is reversed
after treatment with a 5-HT1A agonist. Furthermore, in the adult
rodent brain, 5-HT1A promotes neurogenesis in the subgranu-
lar zone of the dentate gyrus (Brezum and Daszuta, 1999, 2000;
Gould, 1999; Haring and Yan, 1999) and such a role has been pos-
tulated to be a key feature of antidepressant therapies (Guthrie
and Gilula, 1989; Santarelli et al., 2003). Recently, the analysis of
mice lacking MAOA and B, which display high 5-HT levels but
normal dopamine and norepinephrine levels during embryonic
and early postnatal development, revealed a specific reduction
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FIGURE 5 | 5-HT levels impact the migration of GABAergic and
glutamatergic neurons. (A) 5-HT immunoreactivity is present in the
marginal zone (MZ) and in the intermediate zone (IZ) at embryonic day
E17.5, a time point when pyramidal neurons and cortical interneurons
are migrating to constitute upper cortical layers. Upper-layer pyramidal
neurons (in red) are labeled through electroporation of progenitor cells
in the dorsal pallium at E14.5 or E16.5 with a Tomato-expressing
plasmid and interneurons are labeled using GAD65-GFP or 5-HT3A-GFP
transgenic mice. (B) Time-lapse imaging on cortical slices revealed that
an excess of 5-HT and 5-HT6 manipulation affects the migration of
cortical interneurons (B1) and pyramidal neurons (B2) in a reversible
manner. Scale bar: 10μm.
of symmetric divisions of intermediate precursor cells (Corbin
et al., 2008) in the SVZ during late corticogenesis (E17.5; Cheng
et al., 2010). This unexpected alteration was reverted after E14.5–
E19.5 PCPA-treatment. In addition, neurosphere formation was
modulated by 5-HT in a dose-dependent manner in vitro, with
proliferative effects observed for concentration ranging from 10
to 100 ng/ml and inhibitory effects observed for higher concen-
tration (1000 ng/ml). Interestingly, these inhibitory effects were
associated with decreased 5-HT1A labeling of neuronal precursors
(Cheng et al., 2010). Together, these studies identified 5-HT1A as
a largely positive regulator of neuronal proliferation in embryonic
and postnatal life. Hence, 5-HT might modulate cortical density
through its proliferation-inducing action on progenitors.
Additional mechanisms exist through which 5-HT could
potentially modulate proliferation and cortical density. 5-HT
could be involved in modulating the length of the cell cycle or
participate in progenitor cell death regulation. Interestingly, E12–
E17 PCPA-treatment reduces the number of cells expressing Ki67
(a proliferation marker), promotes early GFAP expression, and
impairs the normal development/organization of radial glial pro-
cesses (Vitalis et al., 2007). In turn, early differentiation of RGCs
could reduce cortical neurogenesis. Alternatively, hypo-5-HT
induced microcephaly could be due to increased death of postmi-
totic neurons or neuronal progenitors. Indeed, 5-HT2 stimulation
promotes the survival of glutamatergic neurons in vitro with a
maximal effect observed for stages E16 and E18 in rats (Dooley
et al., 1997), and 5-HT1A stimulation increases neuroprotection
in models of ischemia and protects neuronal cultures against
serum withdrawal (Bielenberg and Burkhardt, 1990; Azmitia
et al., 1995; Ahlemeyer et al., 2000). Furthermore, activation of
5-HT2 reverts increased apoptosis observed in VMAT2:KO mice,
in which dopamine, norepinephrine, and serotonin are depleted
(Stankovski et al., 2007). Such a role was also observed in mice
lacking TrkB, the high affinity receptor for the brain-derived neu-
rotrophins factor (BDNF) and neurotrophin 4, and in both cases
5-HT2 activation was able to normalize the caspase 3–9 cascades
(Vitalis et al., 2002b; Stankovski et al., 2007).
During early development, 5-HT could also influence cortical
proliferation through the modulation of gap junctions that coor-
dinate cell-cell assembly (Guthrie and Gilula, 1989; Lo Turco and
Kriegstein, 1995; Bittman et al., 1997). Interestingly, monoamin-
ergic receptor activation modulates postnatal gap junction cou-
pling in various brain regions including the developing neocortex,
where regulation appears to occur at the level of connexin subunit
phosphorylation (Roerig and Feller, 2000). Pharmacologic evi-
dence suggests that 5-HT promotes uncoupling of gap junctions
through 5-HT2R stimulation (Roerig and Feller, 2000). However,
to our knowledge, no study has investigated the action of 5-HT
receptor modulation on gap junction coupling in the embryonic
cortex.
5-HT AND NEURONAL MIGRATION
5-HT modulates the migration of various cell types and this
effect is maintained across most phyla. For example, 5-HT acts
as a permissive signal that triggers cell motility of mature lym-
phocytes in the vertebrate immune system (chick, fish, rodent;
Khan and Deschaux, 1997; Boehme et al., 2004) and of microglial
cells toward the central nervous system (Krabbe et al., 2012).
In the non-vertebrate developing CNS a role for 5-HT in
promoting-directed neuronal migration has been reported for
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Caenorhabditis elegans (Kindt et al., 2002). In the mammalian
cortex, a role for 5-HT in regulating the migration of cortical
neurons has emerged recently with studies focused on the late
phase of corticogenesis. Using a pharmacological approach and
cortical slices, high 5-HT levels have been shown to decrease
the migratory speed of non-GABAergic and GABAergic neurons
(Riccio et al., 2009, 2011; Figure 5). In cortical explants of E17.5
or P0 mouse brain, in which pyramidal neurons were labeled by
in utero electroporation at E14.5 or E16.5 respectively, neuronal
migration was analysed using video-microscopy in control condi-
tion or after acute bath application of 5-HT. This study revealed
that acute application of high 5-HT concentration leads to a
reversible decrease in the migration speed of glutamatergic neu-
rons running in the IZ. Interestingly, SERT−/− mice exhibit an
abnormal distribution of pyramidal neurons in the most superfi-
cial regions of the CP at E19 (presumptive layers II–III) suggesting
that 5-HT excess could lead to a delay in the migration of cor-
tical pyramidal neurons in vivo. Furthermore, activation of the
5-HT6 receptor recapitulates these events: application of a spe-
cific 5-HT6 agonist to E17.5 or P0.5 cortical explants reduced
the migratory speed of pyramidal neurons labeled at E14.5 or
E16.5 respectively, suggesting that the 5-HT6 receptor is involved
in regulating neuronal migration (Riccio et al., 2011). Similarly to
non-GABAergic neurons, GABAergic neurons expressing GAD65
reversibly and in a dose-dependent manner decrease their migra-
tory speed following acute high levels of 5-HT application ex vivo
(Riccio et al., 2009). 5-HT also induced a retraction of the lead-
ing processes of GABAergic neurons migrating into the IZ and
CP. RT-PCR performed on cells sorted by flow cytometry and
obtained from E18.5 cortical slices of GAD65:GFP mice, revealed
that these cells expressed the 5-HT3A and the 5-HT6 recep-
tors. Again, 5-HT6 agonist application mimicked 5-HT-induced
effects on GABAergic neurons. Furthermore pharmacological
manipulation of the cAMP-signaling pathway partially modulates
the 5-HT6 mediated effects on cortical interneuron migration
(Riccio et al., 2009). Interestingly, recent large-scale proteomic
strategies have revealed that the 5-HT6 receptor binds to a large
variety of signaling molecules that play a critical role during brain
development including the mTOR pathway (Meffre et al., 2012).
It is thus likely that the effects on migration elicited by the phar-
macological manipulation of 5-HT6 receptors also involve these
signaling pathways. Studies are currently underway to test this
hypothesis.
It must be noted that the impact of 5-HT on the migra-
tion of cortical neurons was revealed using high doses of 5-HT.
As in other cell types (Moiseiwitsch and Lauder, 1995), it is
possible that 5-HT produces opposite effects on neuronal migra-
tion depending on the levels of extracellular 5-HT. In cortical
explants maintained in a serum-free medium containing lower
concentration of 5-HT than those used in experiments described
above (5 uM), glutamatergic neurons reach their laminar loca-
tion faster than in explants maintained in serum-free medium
alone, suggesting that 5-HT may enhance the radial migration
of these neurons (Lepore et al., 2001). Furthermore, decreasing
5-HT levels during development delayed or disrupted cortical
migration suggesting 5-HT could also act as a positive drive on
cortical migration (Stankovski et al., 2007; Vitalis et al., 2007).
In animals treated with PCPA during the peak of migration
(E12/E13 to E17 in rats), GABAergic neurons accumulated at
the level of the SP and showed a marked deficit to integrate
in the developing CP (Vitalis et al., 2007). Long-lasting conse-
quences of E12–E17 PCPA-treatment lead to a marked reduction
of CR- and CCK/VIP-positive GABAergic neurons, two neu-
ronal populations that express the 5-HT3A receptor (Férézou
et al., 2007). Interestingly, mice lacking Tph2 also display reduc-
tions of selective GABAergic populations in limbic structures
(Waider et al., 2013). 5-HT3A is protractedly expressed by 30% of
GABAergic neurons and it could be that this population is partic-
ularly sensitive to 5-HT depletion during corticogenesis. 5-HT3A
is associated with F-actin that decorates the tips of the of den-
dritic and axonal growth cones. Interestingly, pharmacological
alteration of F-actin induced a modification in the distribution
of 5-HT3A (Emerit et al., 2002). In addition, 5-HT3A mediates
calcium entry into the cell (see above). Together these results
suggest that 5-HT3A activation could play a role in promot-
ing the migration of cortical interneurons. Such a role is under
investigation.
5-HT AND DIFFERENTIATION
Lauder and Krebs were the first to report that 5-HT depletion
delays neuronal maturation in areas normally receiving 5-HT
afferents (Lauder and Krebs, 1978; Lauder, 1993). These inves-
tigators defined differentiation as the cessation of cell division
measured by incorporation of 3H-thymidine. After these pio-
neering studies, numerous groups have shown that 5-HT can
influence neuritic outgrowth in various phyla (such a role was
intensively investigated in Aplysia) and in various regions of
the CNS (Haydon et al., 1984, 1987; Whitaker-Azmitia et al.,
1996; Lieske et al., 1999; Lotto et al., 1999; Kondoh et al., 2004;
Fricker et al., 2005 and see below). Here we review the role for
5-HT on dendritic and axonal morphogenesis during cortical
development.
5-HT and dendritic maturation of cortical neurons
After termination of neuronal migration, cortical neuron sub-
types differentiate at their specific laminar position and assemble
into precise cortical circuits. During this process, projection neu-
rons extend an elaborated dendritic arbor, which is contacted
by the axons of different subtypes of excitatory neurons and
inhibitory interneurons in a subdomain-specific manner. The
molecular rules that govern the precise connectivity between dif-
ferent subtypes of inhibitory interneurons and excitatory projec-
tion neurons are largely unknown. In this context, reelin-secreting
C-R cells have been identified as key regulators of cortical devel-
opment, including neural migration, neural positioning, and
dendritic arborization (Supèr et al., 2000; Soriano and del Rio,
2005; Lakatosova and Ostatnikova, 2012). C-R cells receive sero-
tonergic projections with which they make transient synaptic
contacts (Janusonis et al., 2004). Reelin secretion is regulated
in part by the amount of brain 5-HT during late embryogene-
sis since 5-methoxytryptamine, a broad 5-HT receptor agonist,
reduces reelin levels circulating in the blood at P0 (Janusonis
et al., 2004). Reduced reelin levels in turn lead to malformation
of microcolumns in the presubicular cortex of the P7 rat pups.
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Microcollumns are the basic microcircuit-units of the cortex
(Jones, 2000;Mountcastle, 2003), and intriguingly are structurally
abnormal in autism spectrum disorder (ASD). The 5-HT3A is
expressed by ∼80% of C-R cells at P0 and its synaptic activation
is sufficient to induce action-potential firing of C-R cells, sug-
gesting that 5-HT3A could play a role in regulating reelin release
and dendritic development (Chameau et al., 2009). Indeed, devel-
opmental 5-HT3A blockade induces a hypercomplexity of apical
dendrites of layers II–III pyramidal neurons sparing the basal
dendrites (Janusonis et al., 2004). In line with this finding, appli-
cation of the N-terminal region of reelin rescued the dendritic
phenotype of cortical pyramidal neurons in 5-HT3A:KO corti-
cal slices, whereas reelin blockade leads to increased growth of
apical dendrites (Chameau et al., 2009). These data suggest that,
increased reelin secretion due to over-activation of the 5-HT3A
receptor would decrease growth of apical dendrites. This hypoth-
esis was recently investigated in vivo using selective 5-HT re-
uptake inhibitors (SSRI). Interestingly, fluoxetine administration
from E8 to E18 decreases the dendritic basal and apical arbor
complexity of layer II/III pyramidal neurons in the somatosen-
sory cortex. This effect is specific to the developmental period
as SSRI have opposite consequences at mature stages (Table 1 in
Homberg et al., 2009). Furthermore, the effects of SSRIs on devel-
oping dendrites were abolished when administered to 5-HT3A:KO
mice or after pharmacological blockade of the 5-HT3A recep-
tor (Chameau et al., 2009; Smit-Rigter et al., 2012). Moreover,
5-HT3A signaling is responsible for the anxiety-like behaviors that
are induced by prenatal fluoxetine treatment in wild type mice
(Smit-Rigter et al., 2010). These results suggest that developmen-
tal excess of 5-HT increases reelin secretion by over-activating
5-HT3A receptors expressed on C-R cells, consequently inhibiting
dendritic growth of pyramidal neurons.
However, other 5-HT receptors may contribute to modulat-
ing the morphology of cortical neurons. The 5-HT1A receptor
for example is also known to modulate dendritic development
(Sikich et al., 1990; Ferreira et al., 2010). Although its role has
not been investigated in the cerebral cortex, several studies have
clearly shown and dissected its role in the hippocampus. Indeed,
mice lacking 5-HT1A display increased dendritic arborization
of CA1 pyramidal cells associated with cognitive impairments
(Klemenhagen et al., 2006; Tsetsenis et al., 2007). Furthermore,
the use of conditional expression of 5-HT1A in mice otherwise
lacking this receptor revealed that it is playing a critical role
during the postnatal window corresponding to dendritic matu-
ration of CA1 pyramidal neurons (Gross et al., 2002). During this
time 5-HT1A appears to limit dendritic growth cone retraction
and extension by possibly remodeling actin filaments (Ferreira
et al., 2010). As 5-HT1A is strongly expressed in the developing
CP (Figure 1 in Bonnin et al., 2006) such a role could also be
expected for cortical neurons. Together these studies suggest that
a fine tuning of 5-HT1A activation may be required for appropri-
ate dendritic maturation of cortical neurons. Finally, one should
keep in mind that 5-HT also act as a trophic factor during devel-
opment and 5-HT deficiency induces a reduction of dendritic
arborization and complexity. Indeed, animals fed with low tryp-
tophan diet (González-Burgos et al., 1996; Feria-Velasco et al.,
2002) or depleted of 5-HT during the embryonic period (Vitalis
et al., 2007) display cortical pyramidal neurons with decreased
dendritic complexity and spine density. It is thus probable that
5-HT regulates dendritic maturation and spine density through
different types of 5-HT receptors that remain to be identified.
5-HT and axonal development within the cerebral cortex
The first clear demonstration that 5-HT acts on cellular processes
involved in the formation of cortical circuits comes from the
work performed on the rodent somatosensory cortex (Figure 6).
The serendipitous generation of a mouse displaying deficiency in
the gene encoding for MAOA was at the starting point of these
discoveries. These studies showed that excessive 5-HT amounts
(nine-fold increase at P0) in the developing cortex induced an
abnormal organization of TCAs growing in the layer IV of the
primary somatosensory cortex (Cases et al., 1995, 1996; Figure 7).
These alterations, that were later interpreted as an abnormal refin-
ing of TC axons, are due to a specific rise of 5-HT occurring
during early postnatal development (P0–P4). Indeed, such alter-
ations could be induced in wild type rodents by pharmacological
inactivation of MAOA during this sensitive period (Vitalis et al.,
1998).
In addition, pharmacological normalization of 5-HT levels in
MAOA:KOmice by P0–P4 PCPA-treatment was sufficient to nor-
malize the organization of S1 in MAOA:KO mice (Cases et al.,
1996; Figure 7). Therefore, the first few days after birth represent
the sensitive time-period for 5-HT effects on axonal segregation
in the rodent barrel cortex. Later, it was shown that genetic SERT
deficiency affected S1 organization similarly. The 5-HT 5-HT1B
and 5-HT1D receptors, that are transiently expressed on TC axons
during development, play a key role in this process, since the
barrel cortex phenotype is rescued in SERT:KO and MAOA:KO
mice that are also deficient for 5-HT1B receptors (Persico et al.,
2001; Salichon et al., 2001; Rebsam et al., 2002; van Kleef et al.,
2012; Figure 7). The general model thus supports the view that
increased extracellular levels of 5-HT lead to an over-activation of
5-HT1B receptors expressed on TCAs. This increased 5-HT1B sig-
naling may inhibit glutamate release by TCAs and impair barrel
cortex formation directly at presynaptic and indirectly at post-
synaptic levels. Interestingly, 5-HT excess does not only impair
S1 organization, since abnormal axonal patterning of TCAs was
also observed in the primary visual cortex (Upton et al., 1999;
Salichon et al., 2001). This intriguing role of 5-HT signaling dur-
ing circuit formation may apply to all primary sensory cortices
that are innervated by neurons transiently capable of 5-HT uptake
(Hansson et al., 1998; Lebrand et al., 1998). Surprisingly, perinatal
5-HT deficiency induces only little changes on the organization of
TCAs. Lowering brain 5-HT levels prenatally using PCPA or PCA
only leads to a reduction of barrel field size (20% average) with-
out altering its general organization (Bennett-Clarke et al., 1994;
Osterheld-Haas et al., 1994; Narboux-Neme et al., 2013).
Although no evidence to date indicates that developmental
excess of 5-HT during stages of embryonic developmental directly
affects the patterning of TCAs, it has been shown that TCAs
express 5-HT1B and 5-HT1D receptors at a time when TCAs are
navigating from the subpallium toward the pallium (Bonnin et al.,
2007). In vivo embryonic down-regulation of 5-HT1B/C receptors
in TCAs using in utero electroporation leads to abnormal TCA
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FIGURE 6 | Deficient 5-HT3A-signaling or embryonic SSRI-treatment
alters the morphologies layers II–III pyramidal dendrites. Serotonergic
afferents (purple) containing large vesicles rich in 5-HT are located in the
marginal zone and below the cortical plate that send branches toward MZ.
5-HT could be released from the entirety of the axonal length. In MZ, 5-HT
fibers make synaptic contacts with C-R neurons that were initially drawn by
Cajal (1891). In control conditions 5-HT activates 5-TH3A receptors located on
C-R neurons. 5-HT and the activation of the 5-HT3A has been shown to
induce reelin secretion that in turn modifies the morphology of apical
dendrites by controlling the growth and sprouting of their arborization. In
absence of 5-HT3A receptor that could be observed in 5-HT3A-knockout mice
or ex vivo following pharmacological blockade of the 5-HT3A the morphology
of apical dendrites become exuberant while basal dendrites that are far from
the source of reelin are preserved. Following SSRI-treatment during
embryogenesis excess extracellular 5-HT leads to an increased reelin
secretion and to a reduction in the complexity of apical and basal dendrites.
pathfinding indicating that 5-HT receptors are functional before
birth and can regulate TCAs guidance at early stages of corti-
cal development (Bonnin et al., 2007). Furthermore, it has been
shown that 5-HT modifies the attractive vs. repulsive responsive-
ness of TCAs to netrin-1 (Bonnin et al., 2007), an important
guidance molecule for TCAs. Given these findings, it is thus likely
that developmental excess of 5-HT could also affect these earlier
stages of thalamocortical pathfinding and lead to abnormal thala-
mocortical long-range wiring (Bonnin and Levitt, 2011; Bonnin
et al., 2012).
FROM RODENTMODELS TO HUMAN
PATHOLOGY–TRANSLATIONAL CONSIDERATIONS
The work reviewed reveals that developmental imbalance of 5-HT
homeostasis or 5-HT receptor signaling has an impact on var-
ious processes involved in the formation of cortical circuits in
rodents. Whether these developmental changes can also occur
in humans remains largely unknown. The nature and severity
of neocortical circuit alterations induced by 5-HT-related per-
turbations are likely to depend on a broad variety of factors
including the timing of the insult. For instance, altered neu-
ronal migration was observed during the late phase of rodent
gestation, a developmental phase which corresponds to the sec-
ond trimester in humans. In contrast, altered dendritic growth
was observed largely during the first two postnatal weeks in
rodents, a phase corresponding to the third trimester in humans.
In this respect, we provide a rodent to human correspondence of
cortical development in Figure 8 to ease comprehension.
One of the most clinically relevant situations leading to a
developmental excess of 5-HT in humans is the exposure of
the human fetus to SSRIs during pregnancy. SSRIs cross the
placenta, reach the developing brain and are poorly metabo-
lized by the fetus. Given the high incidence of mood disorders
in pregnant women, prescription of SSRIs is frequent during this
period. These drugs are considered relatively safe and benefi-
cial during pregnancy, largely because they buffer the negative
effects of maternal stress on the fetal-developing brain with-
out causing major teratogenic effects. However, multiple neg-
ative effects of SSRI treatment during pregnancy have recently
been identified, with the limitation that it is often difficult to
control for confounding effects of maternal psychopathology.
Ultrasonic investigation of human fetuses provides evidence that
SSRIs taken during pregnancy alter the brain physiology start-
ing as early as the beginning of second trimester (Mulder et al.,
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FIGURE 7 | The developmental organization of the somatosensory
cortex depends on brain 5-HT levels. The rodent barrel cortex is
characterized by a one-to-one correspondence between the sensory
system and its cortical projection area (C). Each whisker on the rodent
snout is somatotopically represented in the trigeminal nucleus, the
ventrobasal thalamic nucleus (VB), and the primary somatosensory cortex
(barrel). In the layer IV (IV) of the primary somatosensory cortex (barrel
cortex), cortical barrels are constituted by regions of dense arborization of
thalamocortical afferents (red) and by granular neurons (blue) that
segregate around them. During normal development, SERT, 5-HT1B, and
5-HT1D are expressed transiently by thalamocortical axons (left column). In
SERT:KO or MAOA:KO mice displaying excessive extracellular 5-HT levels
(deep purple) during development the organization of thalamocortical
axons and the segregation of granular neurons are altered (middle
column). 5-HT1B,1D receptors are the direct targets of 5-HT excess. 5-HT1B
receptors act as regulators of thalamocortical development through the
inhibition of glutamate release. Removing the 5-HT1B in MAOA:KO mice is
sufficient to restore a normal thalamocortical organization (right column).
5-HT1B:KO mice display normal barrel organization suggesting that 5-HT1B-
and 5-HT1D-signaling are redundant and that 5-HT1D is sufficient to
maintain a normal organization of thalamocortical axons. However, granular
neurons do not completely segregate suggesting that other 5-HT
receptors, such as the 5-HT2A, could act on granular neurons and
participate in the organization of cortical barrels. (A) Depicts what is
occurring at the thalamocortical and granular interface. (B) Represent the
organization of two adjacent barrels.
2011). Combined recordings of general motor activity, rapid eye
movements, and fetal heart rate variability indicate that fetuses
exposed to SSRIs during gestation have abnormal increases in
motor movements during phases of non-REM sleep compared to
fetuses from drug-free mothers with comparable levels of anxi-
ety and depressive symptoms. Furthermore blood flow recordings
at 36 weeks gestation in the middle cerebral artery were signif-
icantly decreased in fetuses exposed to SSRIs during gestation
(Rurak et al., 2011). At birth, babies prenatally exposed to SSRIs
display a wide range of neurobehavioral alterations, including
lower APGAR scores, increased irritability, and blunted pain
reactivity (Casper et al., 2003; Oberlander et al., 2005), as well
as reduced fetal head growth (El Marroun et al., 2012). More
recently prenatal antidepressants were shown to shift develop-
mental milestones on infant speech perception tasks in utero and
at 6 and 10 month of age (Weikum et al., 2012), suggesting a
role for 5-HT in modulating critical time period maturation in
humans. At later time-points, children exposed to SSRIs during
pregnancy display increased internalizing behaviors (Oberlander
et al., 2010) and decreased scores on psychomotor developmental
scales (Casper et al., 2011). The most worrisome finding comes
from a recent study reporting a two-fold increase in the risk for
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FIGURE 8 | Timing of the human developmental processes in the cerebral cortex. Note that the dashed lines means that the process is active and plain
lines means that the process is at its peak. Adapted from de Graaf-Peters and Hadders-Algra (2006).
autism-spectrum disorders in children exposed to SSRIs during
pregnancy (Croen et al., 2011). The risk appeared higher when
exposure to SSRIs occurred during the second trimester and with
higher dosage of SSRIs, suggesting deleterious effects on early
neural circuit formation.
A second cause of excessive 5-HT-signaling in humans can be
of genetic origin. The common 5-HT transporter-linked poly-
morphic region (SERTLPR) short (s) allele variant leads to
decreased levels of SERT expression in vitro compared to the
long (l) allele, and to a state of SERT hypofunction (Murphy
and Lesch, 2008). This s-allele variant has been extensively inves-
tigated in the field of psychiatry and a large body of work in
non-human primates and humans reveals that the hypofunc-
tional s-allele interacts with early-life adversity to increase risk
for a wide range of psychopathological traits. When exposed
to high levels of maternal anxiety during pregnancy, 6 months
old infants and children carrying the s-allele showed respectively
higher levels of negative emotionality compared to l-allele carriers
(Pluess et al., 2010) and increased scores of anxiety and depres-
sion (Oberlander et al., 2010). Finally an interaction between
the s-allele and severe forms of adversity occurring later during
childhood have been observed in many independent studies and
lead to an increased risk for depressive symptoms in early adult-
hood (Karg et al., 2011). These findings indicate that the common
hypofunctional s-allele is associated to an increased risk to broad
spectrum of psychopathology in the presence of developmental
adversity. The effect size of the s-allele is small and it is thus
likely that the abnormal cortical circuit alterations observed in
SERT deficient rodent models will only occur in humans in more
severe forms of genetic or environmental SERT deficiency. In a
clinical perspective, it is possible that only an accumulation of
risk factors will lead to the cortical circuit alterations detected
in rodents. For example, it is possible that these early life cir-
cuit alterations could emerge in fetuses carrying hypofunctional
SERT variants and being exposed to SSRIs. Furthermore other
risk alleles could interact with SERT deficiency to further increase
the risk for neural circuit alterations. For instance, PTEN, a gene
associated to ASDs (Levitt and Campbell, 2009) interacts with
SERT haploinsufficiency to modify brain size and social behav-
iors in rodents (Page et al., 2009). Overall, these findings point to
the general conclusion that various different clinical dimensions
including autism, depression, and anxiety-related phenotypes are
associated to conditions of SERT deficiency during development.
Knowledge derived from animal studies is beginning to provide
important insight into the developmental and cellular mecha-
nisms that underlie these complex phenotypes. They support the
general hypothesis that developmental excess of 5-HT can lead
to early neural circuit alterations, which will act as an important
vulnerability factor for a spectrum of psychiatric symptoms.
Rodent studies have revealed that the 5-HT3A and the 5-HT6
receptors regulate cellular events involved in cortical circuit for-
mation. However, their implication in determining vulnerabil-
ity to human psychiatric disorders remains to be elucidated.
Interestingly it has been reported that a 5-HT3A genetic variant
interacts with early-life adversity to increase risk for depres-
sive symptoms and decrease fronto-limbic gray matter (Gatt
et al., 2010). In addition this variant also interacts with poly-
morphisms in the brain-derived neurotrophic factor gene to
predict emotion-elicted heart-rate, electroencephalogram asym-
metry, and self-reported negativity bias (Gatt et al., 2010). These
studies point to a potential developmental interaction between
the 5-HT3A receptor and early-life stress in mediating risk for
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mood disorders, confirming the intricate connection between
early-life stress and the serotonergic systems. A role for the
5-HT6 receptor in determining risk for human psychiatric disor-
ders still remains elusive. Human variants in the 5-HT6 receptor
have initially been associated to an increased risk for schizophre-
nia but a recent meta-analyis reported negative findings (Kishi
et al., 2012). Interestingly and in a developmental perspective,
5-HT6 antagonists have recently been shown to reverse cogni-
tive deficits induced by early-life social isolation (Marsden et al.,
2011). In two different developmental rat models of schizophre-
nia specifically neonatal phencyclidine and postweaning isolation,
the mammalian target of rapamycin (mTOR) pathway was found
to be persistently upregulated in the prefrontal cortex (Meffre
et al., 2012). Interestingly it has been shown that 5-HT6 sig-
naling acts on the mTOR pathway and that 5-HT6 antagonists
injected in adulthood could reverse the cognitive defects induced
by early-life insults and normalize mTOR signaling pathway
modifications (Meffre et al., 2012). In a broader perspective pro-
cognitive behavioral effects of 5-HT6 receptor antagonists have
been observed in different types of animal models including
socially isolated reared rats (Marsden et al., 2011). More specif-
ically it has been shown that 5-HT6 receptor antagonists could
reverse deficits in novel object discrimination induced by isola-
tion rearing and that these procognitive effects could be linked
to increased hippocampal-prefrontal cortex glutamatergic neu-
rotransmission, further suggesting the relevance of the 5-HT6
receptor as a potential therapeutical target in cognitive deficits
(Marsden et al., 2011).
PERSPECTIVES
Data obtained in rodents and humans lead to the general hypoth-
esis that genetic and environmental factors that influence 5-HT
signaling during specific sensitive periods of development criti-
cally impact cellular events involved in the formation and mat-
uration of cortical circuits. These various factors act in concert
in predisposing to or protecting against cortical dysfunction. The
central aspect of this conceptual framework is that type and tim-
ing of altered 5-HT signaling determine cortical circuit alterations
and behavioral/cognitive consequences. Future studies will aim to
focus on cell-type specific targets of 5-HT during development
in order to gain a more precise understanding of the diversity
of cellular events and receptors that are involved in cortical cir-
cuit formation. These studies should help us to better understand
how 5-HT signaling during development can impinge on specific
sets of neural circuits and how these circuit specific alterations are
linked to the broad range of behavioral dimensions resulting from
early-life 5-HT dysregulation.
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